For generations, medicine held that higher HDL cholesterol meant a safer heart — a reassuring equation that shaped clinical advice and drove pharmaceutical ambition. A large study drawing on nearly half a million UK Biobank participants now complicates that story, finding that men with very high HDL levels face nearly double the risk of cardiovascular and all-cause death, while women with the same elevated levels show no such penalty. The findings suggest that cholesterol, like most things in biology, resists simple arithmetic — and that the meaning of a number depends deeply on the body in wh
News-Medical.net
· May 23, 2023
· health
· 4 min de leitura
High
Apuração: Verificado
Study challenges 'good cholesterol' myth: very high HDL-C linked to mortality risk in men
◉
Science & Space
6852 artigos relacionados
Blue Origin Probed Over Rocket Failure as Mars Rover Finds Organic Com…
Devdiscourse · 100% correspondência
Israeli radiation vest shows promise for safer deep-space missions
jns.org · 99% correspondência
Starship's Raw Power Masks Mars Challenge: Orbital Refueling Still Unp…
Space Daily · 99% correspondência
South Korean satellite captures SpaceX rocket's lunar impact crater
Google News · 99% correspondência
South Korean Satellite Captures First Images of SpaceX Rocket Crater o…
Google News · 99% correspondência
Cobertura Relacionada
Lokmat Times · Aug 21
Trump to Award Space Medal to Artemis II Crew for Historic Lunar Mission
President Trump will award the Congressional Space Medal of Honour to four astronauts from NASA's Artemis II mission, wh…
Mirage News · Aug 21 Thai Researcher's Mars-Inspired Work on Life's Origins Reaches Chemistry Journal CoverA visiting Thai researcher at UBC Okanagan published groundbreaking work on how life's molecular building blocks assembl…
European Space Agency · Aug 21 ESA's Sophie Adenot to conduct second spacewalk for critical antenna installationESA astronaut Sophie Adenot will conduct her second spacewalk on August 25, 2026, alongside NASA astronaut Anil Menon to…
Space · Aug 21 Japan's MMX mission set to launch Oct. 19 for historic Phobos sample returnJapan's MMX spacecraft will launch October 19 to collect samples from Mars moon Phobos and return them to Earth, a first…
Viés e Enquadramento
⚖
Article presents research findings with scientific framing but uses 'myth' language that may oversimplify complex cholesterol science; generally balanced but lacks counterargument perspectives.
Bias Direction
center
Confidence
MED
Challenge-to-conventional-wisdom framing using 'myth' terminology to emphasize novelty of findings; presents research as definitive despite nuanced gender-specific results
challenges 'good cholesterol' myth
very high HDL-C linked to mortality risk
assumption that higher HDL is always protective
Cardiologists or medical professionals defending the traditional HDL-C guidance
Discussion of why this finding contradicts decades of cardiovascular research
Limitations of the study or reasons for gender-specific differences
Clinical implications and whether guidelines should change based on single study
Perspectives from researchers who maintain HDL-C remains protective at these levels
Impacto Geopolítico
🌎
Medical research finding on cholesterol metabolism has no direct geopolitical implications; this is a health science study without international relations significance.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
Research challenges 'good cholesterol' myth: very high HDL levels (>80 mg/100ml) linked to increased cardiovascular mortality in men, potentially disrupting cholesterol management practices and pharmaceutical strategies.
Market Signal
bearish
Confidence
MED
Pharmaceutical/Biotech (statin and HDL-raising drug manufacturers)
Healthcare/Medical Services
Diagnostic Testing/Laboratory Services
Health Insurance
Wellness/Preventive Health Industry
Consumers may experience confusion about cholesterol management goals; potential reduction in demand for HDL-raising medications and supplements; increased healthcare costs from additional testing to determine individual risk profiles; possible changes in preventive health recommendations affecting insurance premiums and out-of-pocket costs.
Regulatory bodies (FDA, EMA) may require updated clinical guidelines for cholesterol management with gender-specific thresholds; potential reassessment of pharmaceutical approvals for HDL-raising drugs; insurance coverage policies may shift; medical education standards may need revision; public health messaging on cholesterol will require clarification.